Citius Pharmaceuticals, Inc.
CTXR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001506251
No open-market purchases or sales by Citius Pharmaceuticals, Inc. insiders were filed in the last 90 days; 42 institutions reported holding it in 13F filings for Q2 2026, worth $822.4K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Citius Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Citius Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mazur Leonard L | Chief Executive Officer | – | Sep 23, 2025 | 0 |
| Holubiak Myron Z | Vice Chairman | – | Aug 12, 2025 | 0 |
| McGrath Dennis M | Director | – | Nov 12, 2024 | 0 |
| Dutia Suren G | Director | – | Nov 12, 2024 | 0 |
| Webb Carol | Director | 11,835 | Nov 12, 2024 | 0 |
| Holuka Eugene Myron | Director | 2,367 | Nov 12, 2024 | 0 |
| Bartushak Jaime | Chief Financial Officer | – | Nov 12, 2024 | 0 |
| Czuczman Myron | Chief Medical Officer | – | Nov 12, 2024 | 0 |
| Smith Robert Joseph | Director | – | Nov 12, 2024 | 0 |
| Safir Howard | Director | – | Oct 6, 2022 | 0 |
| Kane William | Director | – | Oct 6, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.